OTCMKTS:CNTTFCannTrust Stock Price, Forecast & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market Capitalization$67.40 million

P/E Ratio9.11

Dividend YieldN/A

Beta4.52

CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CannTrust.

2.6 Community Rank

Outperform Votes
CannTrust has received 120 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CannTrust has received 115 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CannTrust has received 51.06% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote “Outperform” if you believe CNTTF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CNTTF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CannTrust does not currently pay a dividend.
Dividend Growth
CannTrust does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CannTrust insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.08% of the stock of CannTrust is held by institutions.

3.1 Earnings and Valuation

Earnings Growth
Earnings for CannTrust are expected to grow by 122.22% in the coming year, from $0.09 to $0.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CannTrust is 9.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of CannTrust is 9.11, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.26.

Overall Beat the Market Rank^™

1.15 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CNTTF

Previous Symbol

CUSIPN/A

CIKN/A

Webcanntrust.ca

Phone64-7872-2300

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio9.11

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$15.96 million

Price / Sales0.00

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding Shares105,640,000

Market Cap$67.40 million

Next Earnings DateN/A

OptionableNot Optionable

Receive CNTTF News and Ratings via Email

Sign-up to receive the latest news and ratings for CNTTF and its competitors with MarketBeat's FREE daily newsletter.

CannTrust (OTCMKTS:CNTTF) Frequently Asked Questions

Has CannTrust been receiving favorable news coverage?

News coverage about CNTTF stock has been trending negative on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CannTrust earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutCannTrust.

Who are some of CannTrust's key competitors?

Some companies that are related to CannTrust include Abeona Therapeutics (ABEO), Aduro BioTech (ADRO), REDHILL BIOPHAR/S (RDHL), Spero Therapeutics (SPRO), MediciNova (MNOV), Fortress Biotech (FBIO), Affimed (AFMD), Northwest Biotherapeutics (NWBO), Mallinckrodt (MNK), Hookipa Pharma (HOOK), XOMA (XOMA), Marinus Pharmaceuticals (MRNS), Inflarx (IFRX), Five Prime Therapeutics (FPRX) and Lexicon Pharmaceuticals (LXRX). View all competitors.

Who are CannTrust's key executives?

CannTrust's management team includes the following people:

Mr. Eric Paul, Co-Founder & Chairman (Age 78)
Mr. Brad Rogers, Pres (Age 49)
Mr. Ian Abramowitz, Chief Financial Officer (Age 64)
Mr. Peter Ralph Aceto, Chief Exec. Officer
Mr. Stanley Abramowitz, Sec. (Age 59)

What is CannTrust's stock symbol?

CannTrust trades on the OTCMKTS under the ticker symbol "CNTTF."

How do I buy shares of CannTrust?

Shares of CNTTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is CannTrust?

CannTrust has a market capitalization of $0.00 and generates $15.96 million in revenue each year.

What is CannTrust's official website?

The official website for CannTrust is canntrust.ca.

How can I contact CannTrust?

CannTrust's mailing address is 3280 Langstaff Road Building 1, Vaughan A6, L4K 5B6. The company can be reached via phone at 64-7872-2300 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff